Algernon Pharmaceuticals

algernonpharmaceuticals.com

Suite 400 - 601 West Broadway

Vancouver, BC Suite V5Z 4C2

Company Info

Year Established
2015

Ticker
AGN

Exchange
CSE

Contacts

Christopher J. Moreau
CEO

Christopher Bryan, PhD
VP, Research & Operations

James Kinley, CPA, CA
CFO

Ahmad Khalil MD PhD
CMO

Company Description

Algernon Pharmaceuticals is a clinical stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis & chronic cough, and COVID-19.